Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Sanctura XR NDA accepted for review

Dec. 15, 2006

Schwarz Pharma transfers urology R&D project to 4SC

Dec. 15, 2006

New agents for urinary incontinence emerge from Astellas Pharma R&D

Dec. 13, 2006

MM-101 ameliorates vesical dysfunction in diabetes model

Dec. 11, 2006

SMP-986 improves voiding efficiency in anesthetized dogs

Dec. 7, 2006

BXL-628 has relevant molecular effects in experimental autoimmune prostatitis

Dec. 7, 2006

Pfizer's novel EP1 receptor antagonist may be useful to treat incontinence

Dec. 4, 2006

Novel agents for treating renal and urological disorders disclosed in recent patents

Dec. 1, 2006

Cetrorelix set to begin phase III for BPH

Dec. 1, 2006

Targets in nephrology

Nov. 29, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...